In Small Study, Low Daily Dose Of Aripiprazole Appears To Benefit People With Parkinson’s Disease And Psychosis

Parkinson’s News Today (3/2, Bryson) reports, “A low daily dose of aripiprazole, an antipsychotic therapy, significantly eased hallucinations and delusions in people with Parkinson’s disease and psychosis,” researchers concluded in an open-label study involving 24 patients with Parkinson’s who had psychosis. The findings were published online in the journal Neuropsychopharmacology.

Related Links:

— “Aripiprazole at Low Dose Eases Parkinson’s Psychosis, If Tolerable “Steve Bryson, Parkinson’s News Today, March 2, 2022

Posted in In The News.